Recap: KemPharm Q2 Earnings

KemPharm KMPH reported its Q2 earnings results on Thursday, August 11, 2022 at 04:05 PM.

Here's what investors need to know about the announcement.

KemPharm missed estimated earnings by 58.33%, reporting an EPS of $-0.19 versus an estimate of $-0.12.

Revenue was down $10.69 million from the same period last year.

Last quarter the company missed on EPS by $0.0 which was followed by a 3.3% drop in the share price the next day.

Here's a look at KemPharm's past performance:

Quarter	Q1 2022	Q4 2021	Q3 2021	Q2 2021
EPS Estimate	-0.05	-0.07	-0.07	0.22
EPS Actual	-0.05	-0.08	-0.06	-0.40
Revenue Estimate	3.06M	2.23M	2.18M	12.10M
Revenue Actual	3.96M	2.60M	1.97M	11.99M

To track all earnings releases for KemPharm visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.